Global Drug Delivery Devices Market – Trends and Forecast to 2022
Global Drug Delivery Devices Market is expected to reach USD 1,625.1 billion by 2022 from USD 950.0 billion in 2015.
The Global Drug Delivery Devices market is segmented on the basis of product, end - user, distribution channel, and geography.
Based on geography the market is segmented into 5 geographical regions North America, Europe, Asia-Pacific, South America and rest of the world. The report of this market covers countries like U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, and South Africa.
For a Sample of the report: http://databridgemarketresearch.com/reports/global-drug-delivery-devices-market/
By Product type:
• Oral
o Solid
o Liquid
o Semi-Solid
• Injectable
o Devices
Conventional,
Self-Injectable,
o Formulations
• Topical
o Transdermal Devices
Patches
Gels
o Formulations
• Pulmonary
o MDI
o DPI
o Nebulizers
• Nasal
• Ocular
• Implantable
• Transmucosal
• Others
By Distribution Channel:
• Hospital Pharmacy
• Pharmacy Stores
• Direct Tenders
• Online Pharmacy
By End-User:
• Hospitals
• Clinics
• Home Healthcare
• Community Healthcare
• Others
The Global Drug Delivery Devices Market is highly competitive and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global drug delivery devices market for North America, Europe and Asia Pacific.
Read More on the market trends of Global Drug Delivery Devices Market: http://databridgemarketresearch.com/drug-delivery-devices-market-poised-grow-8-0/
The key players operating in this market are Bayer AG, Johnson & Johnson, Novartis AG, Pfizer, Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline plc. , Merck & Co., Sanofi, Antares Pharma, 3M, Becton Dickinson and Company, Nemera, Cima Labs, Inc., Dali Medical Devices, Alkermes, Foamis, Ypsomed, Skyepharma AG, Valeant Pharmaceuticals DSM Biomedical and Catalent, Inc. among other vernacular players.
Shubham Dwivedi
Data Bridge Market Research Private Ltd.
+1-888-387-2818
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

